Major Milestone: KB Manufacturing Facility Successfully Completes FDA Inspection with Zero Observations
- KL KBMED
- 5 hours ago
- 2 min read
We are pleased to announce a significant milestone for KB Medical Group Inc. and our manufacturing operations.
Following four days of rigorous on-site inspection, the U.S. Food and Drug Administration (FDA) concluded its inspection of our key manufacturing facility on August 21, 2026, with zero observations and zero deficiencies.
This outstanding result marks another important chapter in our long-standing commitment to quality and regulatory excellence. The facility previously underwent an FDA inspection in 2013, making this successful inspection particularly meaningful after 13 years of continued development, investment, and improvement in our quality management systems.
The inspection, conducted by Senior FDA Inspector Shirley Wen, included an extensive review of the facility’s quality systems, manufacturing controls, documentation, compliance procedures, and overall operational management.
Achieving a result with no deficiencies identified demonstrates the maturity and effectiveness of the factory’s quality management system and reflects its ability to consistently operate in accordance with the stringent regulatory expectations of the U.S. and other major international markets.
As one of KB Medical’s principal manufacturing bases, the facility supports several of our core product categories, including:
This achievement is especially significant as the facility enters its next stage of development. With the new manufacturing facility and expanded production capacity coming into operation in 2026, KB Medical is preparing to further strengthen manufacturing automation, quality control, production capacity, and global supply capabilities.
For KB Medical, regulatory compliance is not simply a requirement—it is the foundation of our commitment to customers, healthcare professionals, and patients worldwide.
13 years after the 2013 FDA inspection, this successful 2026 inspection represents both a recognition of what has been achieved and the beginning of a new chapter.
With expanded facilities, stronger manufacturing capabilities, and an unwavering commitment to quality, KB Medical Group Inc. is ready to move forward into the next stage of global growth.
Quality. Compliance. Reliability.
A new chapter begins in 2026.
